Ken Griffin’s Celularity CELU Stock Holding History

Ken Griffin’s Portfolio CELU Stock Details CELU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-77,657	Closed	-$86.2K	–	13088
2025 Q4	$86.2K	Buy	77,657 +32,901	+74%	+$59K	﹤0.01%	11747
2025 Q3	$92.6K	Sell	44,756 -15,012	-25%	-$42K	﹤0.01%	11892
2025 Q2	$117K	Buy	59,768 +12,822	+27%	+$23.3K	﹤0.01%	11190
2025 Q1	$81.2K	Buy	+46,946	New	+$88.9K	﹤0.01%	11744
2024 Q1	–	Sell	-4,981	Closed	-$20.5K	–	14627
2023 Q4	$12.3K	Buy	+4,981	New	+$10.8K	﹤0.01%	12998
2023 Q3	–	Sell	-1,678	Closed	-$6.03K	–	14343
2023 Q2	$8.94K	Buy	+1,678	New	+$10.7K	﹤0.01%	13286
2023 Q1	–	Sell	-3,721	Closed	-$29.9K	–	14775
2022 Q4	$48K	Buy	+3,721	New	+$68.6K	﹤0.01%	12193
2022 Q2	–	Sell	-7,139	Closed	-$580K	–	12963
2022 Q1	$622K	Buy	7,139 +2,598	+57%	+$156K	﹤0.01%	8862
2021 Q4	$232K	Buy	4,541 +1,194	+36%	+$76.3K	﹤0.01%	11536
2021 Q3	$237K	Sell	3,347 -4,703	-58%	-$380K	﹤0.01%	11590
2021 Q2	$819K	Sell	8,050 -23,333	-74%	-$2.36M	﹤0.01%	8883
2021 Q1	$3.16M	Buy	+31,383	New	+$3.22M	﹤0.01%	5314

Other funds holding CELU

CVSC

C.V. Starr & Co New York $187M AUM 26.03% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Valmark Advisers Akron, Ohio $9.42B AUM 17.63% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

HWM

HB Wealth Management Atlanta, Georgia $17.8B AUM 24.16% 1-Year Est. Return

BFO

Biltmore Family Office Charlotte, North Carolina $761M AUM 31.91% 1-Year Est. Return

Ken Griffin's CELU Position: Q1 2026 in Review

Ken Griffin sold out of Celularity (CELU) in Q1 2026, closing a stake of 77,657 shares — an estimated $86.2K sold.

Ken Griffin first reported a position in CELU in Q1 2021 and held it in 12 quarters. The position peaked at $3.16M in Q1 2021. 38 funds tracked by Wall St. Rank hold CELU as of Q1 2026.

Ken Griffin reported no remaining Celularity position as of Q1 2026 after selling out during the quarter.
Ken Griffin sold 77,657 Celularity shares in Q1 2026, an estimated $86.2K.
Ken Griffin first reported a position in Celularity in Q1 2021 and held it in 12 quarters.
Ken Griffin's Celularity position peaked at $3.16M in Q1 2021.
38 funds tracked by Wall St. Rank held Celularity as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.